Korean J Hematol.  2012 Jun;47(2):155-156. 10.5045/kjh.2012.47.2.155.

Relapse pattern and prognostic factors for patients with primary CNS lymphoma

• Suh C
• Kim JE
• Yoon DH

• KMID: 2083613
• DOI: http://doi.org/10.5045/kjh.2012.47.2.155

Abstract

No abstract available.

MeSH Terms

Humans
Lymphoma
Recurrence

Reference

1. Kim JE, Yoon DH, Kim S, et al. Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma. Korean J Hematol. 2012. 47:60–66.

2. DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol. 2002. 20:4643–4648.

3. Ferreri AJ, Crocchiolo R, Assanelli A, Govi S, Reni M. High-dose chemotherapy supported by autologous stem cell transplantation in patients with primary central nervous system lymphoma: facts and opinions. Leuk Lymphoma. 2008. 49:2042–2047.

4. Morris PG, Abrey LE. Therapeutic challenges in primary CNS lymphoma. Lancet Neurol. 2009. 8:581–592.

5. Thiel E, Korfel A, Martus P, et al. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol. 2010. 11:1036–1047.